专题：Renal Diseases and Glomerulopathies

This cluster of papers focuses on the pathophysiology, genetics, and clinical aspects of glomerular diseases, including nephrotic syndromes such as membranous nephropathy, focal segmental glomerulosclerosis, and IgA nephropathy. It covers topics such as podocyte biology, renal thrombotic microangiopathy, genetic kidney diseases, and the role of the kidney barrier function in disease development.
最新文献
Autosomal dominant polycystic kidney disease

article Full Text OpenAlex

Redefining kidney disease: Clinico-pathological and molecular findings from the Kidney Precision Medicine Project

article Full Text OpenAlex

A severe case of rhabdomyolysis, acute kidney injury, cardiogenic shock, and chronic complications caused by an excessively large dose of Tripterygium glycoside

article Full Text OpenAlex

Spatial Atlas of Human Diabetic Kidney Uncovered Podocyte-Driven Metabolic-Inflammatory Crosstalk via Glycerolipid Reprogramming and DUSP4/MMP3 Axis

article Full Text OpenAlex

Reassessing pravastatin in adult autosomal dominant polycystic kidney disease and potential subgroup benefits

article Full Text OpenAlex

APOL1 plasma membrane pools resist rapid protein degradation

article Full Text OpenAlex

A case of membranous proliferative glomerulonephritis-type IgA nephropathy modified by nintedanib

article Full Text OpenAlex

Single relapse at ≥ 0.5 mg/kg alternate-day prednisone predicts course of childhood nephrotic syndrome

article Full Text OpenAlex

Effect of Steroids on Anti-nephrin Autoantibodies and B cells in Minimal Change Disease

article Full Text OpenAlex

c-Jun N-Terminal Kinase 3 as a Pathogenic Driver of Renal Fibrosis: Imidazo[2,1- b ]thiazole-Based JNK3 Inhibitors Restore Podocyte Function in TGF-β-Mediated Glomerulosclerosis

article Full Text OpenAlex

近5年高被引文献
Epidemiology of chronic kidney disease: an update 2022

review Full Text OpenAlex 2595 FWCI353.6117

Kidney fibrosis: from mechanisms to therapeutic medicines

review Full Text OpenAlex 587 FWCI121.1846

KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS

article Full Text OpenAlex 345 FWCI166.1546

Long-Term Outcomes in IgA Nephropathy

article Full Text OpenAlex 335 FWCI67.4236

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis

article Full Text OpenAlex 330 FWCI46.6731

Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy

article Full Text OpenAlex 300 FWCI40.4752

Molecular pathways that drive diabetic kidney disease

review Full Text OpenAlex 289 FWCI58.6767

Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes

review Full Text OpenAlex 257 FWCI51.821

Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial

article Full Text OpenAlex 241 FWCI48.7965

IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome

review Full Text OpenAlex 239 FWCI30.824